(Q37143670)

English

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation

scientific article published on 04 December 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation (English)

1 reference

Europe PubMed Central

18 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

stem cell transplantation

1 reference

based on heuristic

inferred from title

Robert Peter Gale

12

object named as

Robert P Gale

1 reference

Europe PubMed Central

18 August 2017

Franco Locatelli

19

object named as

Franco Locatelli

1 reference

Europe PubMed Central

18 August 2017

7

object named as

Joseph H Antin

1 reference

Europe PubMed Central

18 August 2017

22

object named as

Morton J Cowan

1 reference

Europe PubMed Central

18 August 2017

26

object named as

Harry Schouten

1 reference

Europe PubMed Central

18 August 2017

18

object named as

Mark R Litzow

1 reference

Europe PubMed Central

18 August 2017

Stephen Spellman

27

object named as

Stephen Spellman

1 reference

Europe PubMed Central

18 August 2017

Steven Z. Pavletic

2

object named as

Steven Z Pavletic

1 reference

Europe PubMed Central

18 August 2017

author name string

Olle Ringdén

1

1 reference

Europe PubMed Central

18 August 2017

Claudio Anasetti

3

1 reference

Europe PubMed Central

18 August 2017

A John Barrett

4

1 reference

Europe PubMed Central

18 August 2017

Tao Wang

5

1 reference

Europe PubMed Central

18 August 2017

Dan Wang

6

1 reference

Europe PubMed Central

18 August 2017

Paolo Di Bartolomeo

8

1 reference

Europe PubMed Central

18 August 2017

Brian J Bolwell

9

1 reference

Europe PubMed Central

18 August 2017

Christopher Bredeson

10

1 reference

Europe PubMed Central

18 August 2017

Mitchell S Cairo

11

1 reference

Europe PubMed Central

18 August 2017

Vikas Gupta

13

1 reference

Europe PubMed Central

18 August 2017

Theresa Hahn

14

1 reference

Europe PubMed Central

18 August 2017

Gregory A Hale

15

1 reference

Europe PubMed Central

18 August 2017

Jorg Halter

16

1 reference

Europe PubMed Central

18 August 2017

Madan Jagasia

17

1 reference

Europe PubMed Central

18 August 2017

David I Marks

20

1 reference

Europe PubMed Central

18 August 2017

Philip L McCarthy

21

1 reference

Europe PubMed Central

18 August 2017

Effie W Petersdorf

23

1 reference

Europe PubMed Central

18 August 2017

James A Russell

24

1 reference

Europe PubMed Central

18 August 2017

Gary J Schiller

25

1 reference

Europe PubMed Central

18 August 2017

Leo F Verdonck

28

1 reference

Europe PubMed Central

18 August 2017

John R Wingard

29

1 reference

Europe PubMed Central

18 August 2017

Mary M Horowitz

30

1 reference

Europe PubMed Central

18 August 2017

Mukta Arora

31

1 reference

Europe PubMed Central

18 August 2017

language of work or name

0 references

publication date

4 December 2008

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

113

1 reference

Europe PubMed Central

18 August 2017

13

1 reference

Europe PubMed Central

18 August 2017

3110-3118

1 reference

Europe PubMed Central

18 August 2017

Risk assessment in haematopoietic stem cell transplantation: minor histocompatibility antigens.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662650

6 September 2017

The graft versus leukemia response after allogeneic hematopoietic stem cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662650

6 September 2017

Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662650

6 September 2017

Adoptive chemoimmunotherapy of cancer in animals: a review of results, principles, and problems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662650

14 September 2017

Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662650

29 September 2017

Graft-versus-leukemia reactions after bone marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662650

29 September 2017

The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662650

27 June 2018

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662650

27 June 2018

T-cell depletion of HLA-identical transplants in leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662650

27 June 2018

Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662650

3 September 2018

Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662650

3 September 2018

No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662650

3 September 2018

Identical-twin bone marrow transplants for leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662650

3 September 2018

Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662650

3 September 2018

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2662650

3 September 2018

Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eleven million donors in Bone Marrow Donors Worldwide! Time for reassessment?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive Factors in Chronic Graft-Versus-Host Disease in Patients with Aplastic Anemia Treated by Marrow Transplantation from HLA-Identical Siblings

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An analysis of factors predisposing to chronic graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

European experience of bone marrow transplantation for leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft versus leukemia effect in man: the relapse rate of acute leukemia is lower after allogeneic than after syngeneic marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate combined with cyclosporin A decreases graft-versus-host disease, but increases leukemic relapse compared to monotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased risk of relapse in patients with chronic myelogenous leukemia given T-cell depleted marrow compared to methotrexate combined with cyclosporin or monotherapy for the prevention of graft-versus-host disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transpla

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the F

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19059878

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2008-07-163212

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37143670&oldid=2100580554"